Ariel Feldstein Selected Research

Ariel Feldstein Research Topics

4	Fibrosis (Cirrhosis) 07/2005 - 04/2003
3	Non-alcoholic Fatty Liver Disease 01/2013 - 04/2004
3	Inflammation (Inflammations) 03/2004 - 04/2003
2	Hepatocellular Carcinoma (Hepatoma) 01/2014 - 07/2005
2	Cholestasis 04/2009 - 07/2003
1	Carcinogenesis 01/2014
1	Insulin Resistance 01/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2011
1	Hepatitis C 04/2009
1	Chemical and Drug Induced Liver Injury 04/2009
1	Dyslipidemias (Dyslipidemia) 04/2004
1	Atherosclerosis 04/2003

2	Glucose (Dextrose)FDA LinkGeneric 07/2005 - 04/2004
2	CXC ChemokinesIBA 03/2004 - 07/2003
1	Stearoyl-CoA DesaturaseIBA 01/2014
1	LipidsIBA 01/2014
1	EnzymesIBA 01/2014
1	Protons (Proton)IBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	Infliximab (Remicade)FDA Link 12/2011
1	Hepatitis A Vaccines (Hepatitis A Vaccine)IBA 12/2011
1	Immunoglobulin G (IgG)IBA 04/2009
1	HCV 796IBA 04/2009
1	Alanine Transaminase (SGPT)IBA 04/2009
1	Antigen-Antibody Complex (Immune Complex)IBA 04/2009
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2009
1	BilirubinIBA 04/2009
1	InterferonsIBA 04/2009
1	Ribavirin (Virazole)FDA LinkGeneric 04/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2004
1	ChemokinesIBA 03/2004
1	Messenger RNA (mRNA)IBA 03/2004
1	LigandsIBA 03/2004
1	CollagenIBA 03/2004
1	CaspasesIBA 03/2004
1	3- (2- (2- tert- butylphenylaminooxalyl)aminopropionylamino)- 4- oxo- 5- (2,3,5,6- tetrafluorophenoxy)pentanoic acidIBA 03/2004
1	Cathepsin BIBA 07/2003
1	oxidized low density lipoproteinIBA 04/2003
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2003
1	Simvastatin (Zocor)FDA LinkGeneric 04/2003
1	CholesterolIBA 04/2003